This bill requires the Federal Aviation Administration to revise its medical-certification rules and related guidance to encourage aviation personnel to seek treatment and to disclose mental health diagnoses or symptoms without automatic disqualification. It directs the FAA to consult with a defined set of aviation and medical stakeholders when updating rules and to implement recommendations from a prior Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee.
Beyond regulatory revisions, the bill builds operational capacity at the FAA’s Office of Aerospace Medicine, establishes recurring review of the special-issuance process for pilots and air traffic controllers, and funds a public information campaign to reduce stigma and broaden awareness of services available to the aviation workforce.
At a Glance
What It Does
The Administrator must update relevant FAA regulations (including part 67) and issue guidance to promote help-seeking and disclosure, implement recommendations from a 2024 rulemaking committee within statutory timeframes, and conduct annual reviews of the mental-health special-issuance process. The bill also designates multi-year funding for recruiting and training aviation medical examiners and for a public education campaign.
Who It Affects
Primary operational groups are pilots and air traffic controllers who use FAA medical certification, aviation medical examiners who evaluate them, and FAA’s Office of Aerospace Medicine which implements and oversees special issuances. Airlines, flight schools, and airports are secondary participants via required collaboration on outreach and information-posting.
Why It Matters
The measure shifts policy emphasis from exclusion toward clinical management and workforce retention—potentially changing which treatments and medications are treatable within certification frameworks and how AMEs make clearance decisions. That shift touches safety assessment, privacy practices, and FAA resource needs.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill directs the FAA to revise medical-certification regulations to encourage individuals performing aviation activities to both seek treatment for mental-health concerns and to disclose such conditions. The regulatory update mandate explicitly reaches part 67 of title 14 and is paired with FAA guidance aimed at reducing disincentives to report mental-health symptoms.
The statutory language ties regulatory change to stakeholder consultation and to the work of an existing task group created under the FAA Reauthorization Act of 2024.
The statute amends the 2024 task-group reporting structure to require the group to review National Transportation Safety Board recommendations and to document the clinical studies, diagnostic protocols, and professional standards that licensed clinicians use. It also expands the list of stakeholders the task group must consult—naming exclusive bargaining representatives for FAA air traffic controllers, pilot collective-bargaining organizations, accredited aviation education institutions, and other relevant parties—so that the task group’s reports reflect operational and clinical perspectives.To accelerate change, the bill imposes specific internal deadlines and accountability steps: the Administrator must take ‘‘appropriate action’’ to implement task-group recommendations within 180 days of receiving required reports, and if the FAA declines a recommendation it must provide a written justification to designated appropriations and authorizing committees within 90 days.
Separately, the bill requires the FAA to implement recommendations of the Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee within two years, subject to the same congressional justification process if the FAA does not implement an item.The measure also creates recurring programmatic activities. Beginning 180 days after the FAA submits its first required task-group report, the Administrator must conduct annual reviews of the mental-health special-issuance process with an eye toward reclassifying eligible medications and evidence-based treatments, improving AME training, and expanding circumstances where an AME may issue a certificate consistent with the ARC’s recommendations.
To support implementation, the bill designates multi-year funds for the Office of Aerospace Medicine to recruit and train additional AMEs (including psychiatrists), clear backlogs of special-issuance requests, and enhance oversight capacity.Finally, the bill funds and prescribes features of a public information campaign designed to destigmatize help-seeking among current and prospective aviation workers. The campaign must post materials online in accessible formats, make them available at Aviation Medical Examiner offices, and encourage air carriers, flight schools, and airports to promote the information.
The FAA must brief Congress shortly after launching the campaign and report on stakeholder engagement and feedback within two years of implementation.
The Five Things You Need to Know
The Administrator must update FAA medical-certification regulations (including part 67) to encourage treatment and disclosure and issue related guidance within 2 years of enactment.
The FAA must implement recommendations from the Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee within 2 years or submit a written justification to four congressional committees within 90 days of the deadline.
The bill requires the FAA to act on task-group recommendations within 180 days after each required report, and if it does not implement a recommendation it must explain that decision to appropriations and authorizing committees within 90 days.
The Office of Aerospace Medicine receives designated funding authority of up to $15 million per year for fiscal years 2026–2029 to recruit/train AMEs, expand oversight, and clear special-issuance backlogs.
The FAA must run a public information campaign funded at up to $1.5 million per year for fiscal years 2026–2029, post destigmatizing materials online and in AME offices, and partner with carriers, training institutions, and airports on outreach.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions and scope
This section supplies operational definitions used throughout the bill—‘Administrator,’ ‘FAA,’ ‘special issuance,’ and the congressional committees that must receive notifications and justifications. Defining ‘special issuance’ by reference to 14 C.F.R. § 67.401 anchors subsequent obligations to the existing medical-certificate exception framework rather than creating a new statutory certificate type.
Mandate to update regulations and guidance
The Administrator must update FAA regulations, explicitly including part 67, and publish guidance ‘‘as appropriate’’ to encourage treatment-seeking and disclosure among those performing aviation activities. Practically, this requires rulewriters to review medical-eligibility standards and to craft guidance that reduces punitive deterrents while preserving FAA safety responsibilities.
Task-group reporting, consultation, and implementation deadlines
The bill amends the FAA Reauthorization Act of 2024’s task-group reporting requirements to add a mandated review of NTSB recommendations and to require documentation of the clinical resources used by licensed professionals. It also mandates consultation with specified stakeholder groups and forces implementation action within 180 days of task-group reports, with a 90-day congressional-justification requirement if the FAA elects not to act. Those deadlines create institutional pressure to convert studies and recommendations into regulatory or policy changes.
Annual review of mental-health special issuance
Starting 180 days after the FAA files its first required report, the Administrator must annually review the special-issuance process and update regulations, policies, and guidance as appropriate. The review explicitly targets reclassification of medications and evidence-based treatments, improving AME training, and expanding circumstances in which AMEs may clear candidates—changes that could alter which treatments are compatible with flying duties.
Funding to expand Office of Aerospace Medicine capacity
The bill directs the FAA to allocate up to $15 million per year (FY2026–FY2029) from existing designated funds to recruit and train additional aviation medical examiners (including psychiatrists), expand oversight, and clear special-issuance backlogs. This is a directed use of agency-available appropriations and signals a recognition that implementation requires both personnel and administrative capacity, not just rule changes.
Implement ARC recommendations and run public information campaign
Section 6 requires the FAA to implement, as appropriate, the Mental Health and Aviation Medical Clearances ARC recommendations submitted April 1, 2024, within two years and to consult the expanded stakeholder list. Section 7 authorizes up to $1.5 million per year (FY2026–FY2029) for a public information campaign that must publish accessible materials online, place information in AME offices, collaborate with carriers, training institutions, and airports, brief Congress within 90 days of establishment, and report on engagement within two years.
This bill is one of many.
Codify tracks hundreds of bills on Transportation across all five countries.
Explore Transportation in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pilots with treatable mental-health conditions — the bill promotes pathways for disclosure and treatment without automatic disqualification, and it creates mechanisms (annual reviews, ARC implementation) that may broaden acceptable therapies and medications under special issuance.
- Air traffic controllers — similar to pilots, controllers gain clearer processes for medical certification tied to updated clinical standards, plus outreach intended to reduce stigma and encourage early help-seeking.
- Aviation Medical Examiners (AMEs) and the Office of Aerospace Medicine — the bill provides targeted funding for recruitment and training, plus clearer clinical guidance and an expectation of upgraded oversight, which can improve decision consistency and professional support.
- Air carriers, flight training institutions, and airports — better-defined certification paths and a destigmatizing outreach campaign could reduce unanticipated workforce attrition and clarify hiring/training pipelines.
- Safety and workforce planners at the FAA — formalized review cycles, mandated consultations, and documentation requirements give FAA leadership better data and a repeatable governance structure for balancing clinical advances and operational safety.
Who Bears the Cost
- FAA’s Office of Aerospace Medicine — while the bill directs funds to the office, it also tasks the office with recruiting, training, oversight expansion, clearing backlogs, and meeting multiple reporting deadlines; those are resource- and management-intensive obligations.
- Aviation Medical Examiners — new training expectations, heightened oversight, and potential expansion of circumstances in which they can issue certificates will require time, continuing education, and possibly new clinical protocols.
- Air carriers, flight schools, and airports — required collaboration and encouragement obligations for the outreach campaign mean operational entities must allocate personnel time and platforms to share FAA materials and respond to engagement.
- U.S. taxpayers / appropriations — the bill designates multi-year sums from FAA-available funds for staffing and outreach; those funds will need to be accommodated within agency budgeting priorities.
- Pilots and controllers seeking special issuance — expanded evaluation and documentation expectations and possibly more medical oversight could increase medical-evaluation steps and paperwork, at least during transition.
Key Issues
The Core Tension
The central dilemma is between reducing the professional penalty for seeking mental-health care—which encourages disclosure and treatment—and the FAA’s duty to maintain an uncompromised safety standard; loosening medical-certification barriers can preserve workforce capacity and wellbeing, but doing so without robust, evidence-based criteria and adequate oversight could expose operations to new risks.
The bill balances two legitimate aims—improving public-safety outcomes by ensuring mental-health conditions are clinically managed, and reducing deterrents to disclosure—but implementation creates knotty operational questions. The statutory deadlines and justification requirements push the FAA to convert recommendations into action, but meaningful change depends on clinical consensus about which medications and therapies are compatible with flying duties.
Reclassifying medications or expanding AME authority without robust, consensus-based clinical standards risks uneven adjudication and potential safety trade-offs.
Resource allocation and execution also pose practical challenges. The bill earmarks funding for FY2026–FY2029, but success depends on whether those funds are sufficient and on the FAA’s ability to recruit qualified psychiatrists and AMEs in a competitive market.
The public-information campaign aims to reduce stigma, yet without parallel guarantees about confidentiality and nonpunitive medical-clearance pathways, outreach may raise expectations the FAA cannot uniformly meet. Finally, the requirement to document clinical studies and protocols and to consult many stakeholders creates the potential for lengthy negotiation and for recommendations that are technically sound but operationally difficult to implement at scale.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.